|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Immucor (BLUD) Announces 2 Million Share Increase to Stock Repurchase Program
8/19/2009
NORCROSS, Ga., Aug. 18 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that its board of directors has authorized an additional 2 million common shares for repurchase under its current stock repurchase program. "Share repurchase is a good use of our free cash flow," stated Dr. Gioacchino De Chirico, Immucor's President and Chief Executive Officer. "We believe in the long-term potential of Immucor and remain committed to actions that deliver value to our shareholders." About Immucor Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com. Immucor, Inc.
|
|
|
|
|
|
|
|
|
|
|
|